Search results
Results from the WOW.Com Content Network
Branch Retinal Vein Occlusion Study (BRAVO)b. Multicenter, double-masked, prospective, Phase III RCT. Ranibizumab (Lucentis®) intravitreal injections (0.3 mg or 0.5 mg) vs. Sham injections for BRVO-associated CME. Ranibizumab-treated patients have less CME compared to sham group at 6 months ; Both doses of Ranibizumab are rapidly effective
Figure 1: 31-year-old female presented with an acute onset inferonasal visual field defect in the right eye and found to have a superior branch retinal artery occlusion (Figure 1). No emboli or Hollenhorst plaques were seen in either eye. Workup included an EKG, carotid doppler, cardiac echo, ANA, ACE, RF, CBC, PT/PTT, anticardiolipin ab, RPR ...
Signs/Symptoms. Pain associated with trochleitis is typically exacerbated both by up- and downgaze, especially in adduction. Physical examination is significant for erythema, edema, and point tenderness immediately overlying the superior oblique muscle and tendon in the trochlear region.
Nov 18 - Resident Interview Day. Dec 6- Resident Interview Day. The Ophthalmology Update is a newsletter for employees of the Department of Ophthalmology. Editor & staff writer: Kelsey Hunold (7-8001) ; staff writers: Caroline Allen ; Joe Schmidt ; copy editor: Peg Harris; Department Head: Keith D. Carter, MD.